24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Equashield
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:27
Nikesh Arora’s $10 million bet keeps paying off as Palo Alto Networks crosses $330 billion
15:39
From working at her family’s dry cleaner to an $8.2 billion AI deal: Fei-Fei Li’s journey
15:02
SentinelOne AI researcher uses GPT-6 Astra to crack Napoleon cipher after 217 years
13:15
We gave AI agents the organization's keys - but what are they’re doing with them?
More stories
Buzz
Most popular
Daily
Weekly
1
Nikesh Arora’s $10 million bet keeps paying off as Palo Alto Networks crosses $330 billion
2
SentinelOne AI researcher uses GPT-6 Astra to crack Napoleon cipher after 217 years
3
Palo Alto Networks becomes first company to hit NIS 1 trillion on Tel Aviv Stock Exchange
4
Snyk laid off 20% of its workforce after writing off technology from Israeli acquisitions Helios and Enso
5
Nebius acquires 10-month-old stealth AI startup Inferize in $100-150 million deal
More news
Equashield
1 stories about Equashield
Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation
06.10.22
|
Golan Hazani
CEO and co-founder Eric Shem-Tov is the largest shareholder at the company, which has registered sales in the hundreds of millions of dollars to hospitals across the world for its manual and automated solutions for the compounding and administration of hazardous drugs